HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer
Clinical trial NCT02523417 · COMPLETED
Trial details
- NCT number
- NCT02523417
- Sponsor
- Fuda Cancer Hospital, Guangzhou
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2016-02-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.